Sharon Grimster (ReNeuron) and Sarah Goulding (Knowledge Transfer Network) to be recognised at bioProcessUK conference
Sharon Grimster of ReNeuron and Dr Sarah Goulding of the Knowledge Transfer Network (KTN) will be awarded the prestigious Peter Dunnill award and Richard Wilson impact award respectively, at the UK BioIndustry Association’s (BIA) 16th bioProcessUK conference in Liverpool later this month.
The pair have been recognised for their work and contributions to the bioprocessing and biologics manufacturing sector. The Peter Dunhill award was established following the death of Professor Peter Dunnill to mark his lifetime contribution to bioprocessing, and the Richard Wilson Impact Award acknowledges those who are making a significant impact in the bioprocessing sector.
Steve Bates OBE, Chief Executive of the BIA said: “I’m delighted that Sharon and Sarah are receiving these awards, this is recognition of their hard work over many years in helping build the vibrant and world leading UK bioprocessing sector we have today. They have been trailblazers in the bioprocessing sector and their work in bringing together the different parts of the ecosystem has greatly benefitted the UK sector, companies and patients.”
Sharon Grimster, VP and General Manager for Wales at ReNeuron, winner of the Peter Dunnill award said: “Receiving this award is a great honour, and I am thankful to all of those that I have had the opportunity to work with and learn from in this vibrant bioprocessing community. The support of organisations such as the BIA, Innovate UK, CGTC, MMIP, and the excellent industry focussed universities further enable us all to make significant contributions to the original vision of the Bioprocess Industry and Growth Team report of 2005.
“I have been fortunate to have started my career in the early days of recombinant protein therapeutics at Celltech and to have learnt many lessons with both small and large molecules in small and large organisations, before taking on my current role at ReNeuron, where Advanced Therapy Medicinal Products (ATMPs) are managing to shift the dial in terms of potential treatments for unmet clinical needs.”
Dr Sarah Goulding, Specialist in advanced therapies and medicines at KTN, winner of the Richard Wilson impact award said: “I am surprised, delighted and very humbled to receive this award from peers at bioProcessUK. It is a privilege to work with a community that is so welcoming, energetic and passionate about making a difference in how we manufacture the medicines of the future.”
Notes to editors:
1. The award will be presented at the bioProcessUK conference in Liverpool on 26 – 28 November. Delegate tickets and press passes are still available for the event.
2. For more on Sharon’s background please follow this link
3. For more on Sarah’s background please follow this link.
4. Please follow this link for information on previous winners of the Peter Dunnill and Richard Wilson Impact awards.
5. For more information contact Shannon Quinney, Communications Executive at the BIA on firstname.lastname@example.org or 02076302201
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.